Matthias Preusser, Sabine Spiegl-Kreinecker, Daniela Lötsch, Adelheid Wöhrer, Maria Schmook, Karin Dieckmann, Walter Saringer, Christine Marosi and Walter Berger Trabectedin has promising antineoplastic activity in high-grade meningioma Cancer 118
Article first published online: 5 MAR 2012 | DOI: 10.1002/cncr.27460
Aggressive meningiomas are rare but are a therapeutic challenge. The current data indicate that the novel antineoplastic agent trabectedin, which is used for sarcomas and ovarian cancer, may be a promising new therapeutic option for aggressive meningiomas.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.